1. Home
  2. TEVA vs DGX Comparison

TEVA vs DGX Comparison

Compare TEVA & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • DGX
  • Stock Information
  • Founded
  • TEVA 1901
  • DGX 1967
  • Country
  • TEVA Israel
  • DGX United States
  • Employees
  • TEVA N/A
  • DGX N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • DGX Medical Specialities
  • Sector
  • TEVA Health Care
  • DGX Health Care
  • Exchange
  • TEVA Nasdaq
  • DGX Nasdaq
  • Market Cap
  • TEVA 19.7B
  • DGX 17.0B
  • IPO Year
  • TEVA N/A
  • DGX 1996
  • Fundamental
  • Price
  • TEVA $18.38
  • DGX $157.15
  • Analyst Decision
  • TEVA Strong Buy
  • DGX Buy
  • Analyst Count
  • TEVA 8
  • DGX 13
  • Target Price
  • TEVA $19.25
  • DGX $154.46
  • AVG Volume (30 Days)
  • TEVA 4.9M
  • DGX 698.0K
  • Earning Date
  • TEVA 11-06-2024
  • DGX 10-22-2024
  • Dividend Yield
  • TEVA N/A
  • DGX 1.89%
  • EPS Growth
  • TEVA N/A
  • DGX 11.56
  • EPS
  • TEVA N/A
  • DGX 7.44
  • Revenue
  • TEVA $16,290,000,000.00
  • DGX $9,539,000,000.00
  • Revenue This Year
  • TEVA $4.59
  • DGX $4.95
  • Revenue Next Year
  • TEVA $4.06
  • DGX $5.86
  • P/E Ratio
  • TEVA N/A
  • DGX $21.17
  • Revenue Growth
  • TEVA 8.48
  • DGX 2.60
  • 52 Week Low
  • TEVA $8.07
  • DGX $120.87
  • 52 Week High
  • TEVA $19.08
  • DGX $159.36
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 59.65
  • DGX 63.51
  • Support Level
  • TEVA $17.73
  • DGX $146.91
  • Resistance Level
  • TEVA $18.33
  • DGX $150.59
  • Average True Range (ATR)
  • TEVA 0.38
  • DGX 3.00
  • MACD
  • TEVA 0.10
  • DGX 0.37
  • Stochastic Oscillator
  • TEVA 93.00
  • DGX 84.59

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Share on Social Networks: